{"organizations": [], "uuid": "1e9a540427bdb49778b3a6d6bf17b4fb508ef9fe", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180517.html", "section_title": "Archive News &amp; Video for Thursday, 17 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-trial-shows-pfizers-lyrica-reduces/brief-trial-shows-pfizers-lyrica-reduces-seizures-in-children-with-epilepsy-idUSASC0A2RB", "country": "US", "domain_rank": 408, "title": "BRIEF-Trial shows Pfizer's Lyrica reduces seizures in children with epilepsy", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.996, "site_type": "news", "published": "2018-05-17T20:23:00.000+03:00", "replies_count": 0, "uuid": "1e9a540427bdb49778b3a6d6bf17b4fb508ef9fe"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-trial-shows-pfizers-lyrica-reduces/brief-trial-shows-pfizers-lyrica-reduces-seizures-in-children-with-epilepsy-idUSASC0A2RB", "ord_in_thread": 0, "title": "BRIEF-Trial shows Pfizer's Lyrica reduces seizures in children with epilepsy", "locations": [], "entities": {"persons": [], "locations": [{"name": "pregabalin", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "negative"}, {"name": "pfizer inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 17 (Reuters) - Pfizer Inc:\n* LYRICAÂ® (PREGABALIN) ORAL SOLUTION CV PHASE 3 TRIAL IN PEDIATRIC EPILEPSY MEETS PRIMARY ENDPOINT\n* PFIZER - POSITIVE TOP-LINE RESULTS OF PHASE 3 STUDY EXAMINING USE OF LYRICA ORAL SOLUTION CV AS ADJUNCTIVE THERAPY\n* PFIZER - RESULTS SHOWED ADJUNCTIVE TREATMENT WITH LYRICA 14 MG/KG/DAY RESULTED IN STATISTICALLY SIGNIFICANT REDUCTION IN SEIZURE FREQUENCY VERSUS PLACEBO\n* PFIZER INC - TREATMENT WITH LYRICA AT LOWER DOSE DID NOT RESULT IN STATISTICALLY SIGNIFICANT REDUCTION IN SEIZURE FREQUENCY VERSUS PLACEBO Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-17T20:23:00.000+03:00", "crawled": "2018-05-18T19:40:53.001+03:00", "highlightTitle": ""}